Your browser doesn't support javascript.
loading
Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.
Farmer, Cristan A; Gilbert, Jessica R; Moaddel, Ruin; George, Jomy; Adeojo, Lilian; Lovett, Jacqueline; Nugent, Allison C; Kadriu, Bashkim; Yuan, Peixiong; Gould, Todd D; Park, Lawrence T; Zarate, Carlos A.
Afiliação
  • Farmer CA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Gilbert JR; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Moaddel R; National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • George J; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD, USA.
  • Adeojo L; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD, USA.
  • Lovett J; National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Nugent AC; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Kadriu B; Magnetoencephalography Core Facility, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Yuan P; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Gould TD; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Park LT; Departments of Psychiatry, Pharmacology, and Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Zarate CA; Veterans Affairs Maryland Health Care System, Baltimore, MD, USA.
Neuropsychopharmacology ; 45(8): 1405, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32376872

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Neuropsychopharmacology Assunto da revista: NEUROLOGIA / PSICOFARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Neuropsychopharmacology Assunto da revista: NEUROLOGIA / PSICOFARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido